Abstract
Sialorrhoea is the involuntary spillage and flow of saliva from the mouth affecting 10% of patients with chronic neurological diseases. Current management includes systemic anticholinergic medication, behaviour modification and surgery. All of these methods may have significant side effects or can be difficult to use in this population. Botulinum toxin is successful in reducing sialorrhoea with minimal and reversible side effects, however the effects are temporary. Surgical alternatives of submandibular gland excision or duct rerouting remain the gold standard for long term treatment.
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
